CGAS and Alzheimer disease: Interestingly, APP and GAS signaling pathways were significantly activated in human AD brain tissue (Figure 8E), consistent with prior reports linking abnormal activation of APP and cGAS to AD pathology and cognitive resilience changes [39, 40, 41, 42].